For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

REXULTI® (brexpiprazole), SZ

Lundbeck and Otsuka reports positive data from phase 3 trial of

For Alzheimer's Agitation, Promising News from Rexulti

Otsuka Pharmaceutical and Lundbeck present positive results

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Antipsychotic Shows Benefit for Alzheimer's Agitation

FDA nod for Rexulti sNDA in treatment of Alzheimer's agitation

Drugs Archives - Alzheimer's & Dementia Weekly

Otsuka and Lundbeck Announce U.S. Food and Drug Administration

FAQ for agitation that may happen with dementia due to Alzheimer's